Tag - moderna

 
Menu
Search
 
November 22, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

MODERNA

Japan Times
WORLD / Science & Health
Dec 23, 2020
How vaccine-makers are preparing for mutant coronavirus strains
Drugmakers have said they could reset the COVID-19 shot to counter a new strain within just six weeks.
Japan Times
COMMENTARY / World
Dec 12, 2020
Vaccines alone aren’t enough to beat COVID-19
While an effective vaccine is sure to help, a safe oral antiviral drug would truly step up efforts to fight the pandemic.
Japan Times
WORLD
Nov 30, 2020
Moderna to seek U.S. and EU clearance for COVID-19 vaccine
The move came after a new analysis showed the vaccine was highly effective in preventing COVID-19 with no serious safety problems.
Japan Times
JAPAN / Science & Health
Nov 25, 2020
Not so fast, Japan experts say, as COVID-19 vaccines raise hopes
Medical experts say long-term safety and efficacy concerns remain as the vaccines are developed in record-setting time.
Japan Times
COMMENTARY
Nov 22, 2020
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
Japan Times
COMMENTARY / World
Nov 21, 2020
Why Moderna’s vaccine win is a giant leap against pandemics
Alongside recent results from Pfizer, the news that a vaccine is proving effective is a great step forward.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD / Science & Health
Nov 17, 2020
Moderna’s COVID-19 vaccine: What you need to know
Coming a week after similar news from Pfizer and BioNTech, Moderna's announcement offered more hope that there's going to be a way out of the pandemic.
Japan Times
WORLD / Science & Health
Nov 17, 2020
WHO warns against COVID-19 complacency after Moderna vaccine news
'Right now we are extremely concerned by the surge in cases we are seeing in some countries,' WHO director-general Tedros Adhanom Ghebreyesus told a news briefing.
Japan Times
WORLD / Science & Health
Nov 17, 2020
How the Moderna and Pfizer coronavirus vaccines stack up
The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.
Japan Times
WORLD
Nov 16, 2020
Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection
A key advantage of Moderna's vaccine is that it does not need ultracold storage like Pfizer's, making it easier to distribute.
Japan Times
WORLD / Science & Health
Nov 12, 2020
Moderna COVID-19 vaccine trial reaches key goal to gauge merit
The bet among top experts in the field is that Moderna's therapy will likely prove to be highly effective.
Japan Times
WORLD / Science & Health
Nov 4, 2020
Oxford COVID-19 vaccine trial results due this year but not there yet, trial chief says
A vaccine that works is seen as a game-changer in the battle against the coronavirus, which has killed more than 1.2 million people worldwide.
Japan Times
WORLD / Science & Health
Sep 18, 2020
COVID-19 vaccine leaders make trial plans public in transparency push
The moves come amid increasing concern that the effort to develop a COVID-19 vaccine is becoming politicized.
Japan Times
BUSINESS / Companies
Jul 14, 2020
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.
Japan Times
WORLD / Science & Health
Jul 7, 2020
Moderna spars with U.S. scientists over COVID-19 vaccine trials
As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc., one of the leading developers, it has been learned.
Japan Times
BUSINESS
Jul 3, 2020
How Moderna execs are cashing in during the race to develop COVID-19 vaccine
Biotech firm Moderna Inc. could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.
Japan Times
BUSINESS / Companies
Mar 31, 2020
Firms sign deals with U.S. to prep for mass-producing virus vaccines
The U.S. government has cut deals with Johnson & Johnson and Moderna Inc. and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines even before safe and effective ones become available.
Two of America’s biggest debt holders are dumping Treasurys
The U.S. Treasury building in Washington. Investors in Japan and China sold a pile of U.S. debt in the last quarter, just before the U.S. presidential election.
Ishiba aggravates his own political failures with diplomatic faux pas
Prime Minster Shigeru Ishiba is greeted at the APEC summit in Lima by Canadian Prime Minister Justin Trudeau on Friday. The Japanese leader was criticized for remaining seated while meeting several world leaders at the event.
Japan's 3.31 million visitors in October set monthly record
Kiyomizu Temple in Kyoto in December 2023. Famous autumn leaf colors contributed to increased tourism demand last month from many markets across Asia, Europe and North America, the Japan National Tourism Organization has said.
Japan ranks last in romance satisfaction for second straight year
In a survey of 31 countries, Japan ranked last in terms of those who felt loved, with just 51% of respondents saying so.
Ruling coalition and DPP strike last-minute deal over economic policy
DPP policy chief Makoto Mahaguchi speaks at the party's policy gathering in Tokyo on Wednesday.
Japan, U.K. and Italy discuss inviting more countries to joint fighter project
A new concept model of a next-generation fighter jet to be jointly developed by Japan, Britain and Italy is on display in Farnborough, Hampshire, in July.
Haruki Murakami's 'The City and Its Uncertain Walls' gives deep deja vu
For “The City and Its Uncertain Walls,” translated into English by Philip Gabriel, Haruki Murakami confronts the ghosts who won't leave him alone.
Japanese expats in Asia find community through rugby
The Taiwan Fivewoods celebrate their victory at the 2023 Asian Japanese Rugby Cup in December of last year.
In Fukushima, a weekend of prose, poetry and translation
Aomori-based writer JJ Carter presented on tabletop gaming as creative inspiration for building characters and narratives.
For Dr. Nakamats, aging is just experience in action
Though he didn't win the recent gubernatorial election in Tokyo, the 96-year-old Dr. Nakamats' run was seen as inspirational in Japan's aging society.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

Azabudai Hills, Tokyo’s green new downtown ‘village’
Azabudai Hills, Tokyo’s green new downtown ‘village’

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER